Use of Artificial Intelligence-Guided Echocardiography to assIst cardiovascuLar Patient managEment
Recruiting · NCT05558605 · Interventional (participants receive a specific treatment) · Lead sponsor: Baker Heart and Diabetes Institute
View the official record on ClinicalTrials.gov →Interventions studied
AI-guided echoStandard echo
What this trial is about
Heart Failure and valvular heart disease are disproportionate problems in rural and remote Australia (RRA). Echocardiography is the best imaging investigation, and essential for management, but access to this essential test shows huge geographic variations, primarily because of dependence on expert acquisition. This trial seeks to demonstrate the effectiveness of artificial intelligence-based echocardiography for triage and management of patients with known or suspected heart disease in RRA.
Who can take part
Age range
45 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age \>45 years
- eligible for Medicare
- exercise intolerance or cardiovascular (CV) risk factors
Exclusion criteria
- Known HF or HVD
- situations where cardio-protection is already indicated (eg. known CAD)
- comorbid conditions with life expectancy \<2 years
- inability to provide written informed consent
Where it is running
1 location listed.
- Alice Springs Hospital - Alice Springs, Northern Territory, Australia